Internal Medicine, Medical Oncology · Everett, WA
NPI
1891748331
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1717 13th St
Everett, WA, 98201
Phone (425) 297-5571
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
44,821 services
Medicare patients, 2024
459
Average age 75
Drug cost, 2024
$4.9M
1,243 prescriptions
Company payments, 2025
$22.8
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yoshio Inoue was code J9271 (injection, pembrolizumab, 1 mg), 5,200 times for 12 patients. In total Yoshio Inoue billed 44,821 services in 128 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 5,200 | 12 | $44.38 | $231K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 3,900 | 39 | $0.09 | $367 |
| 85025 Blood Count | Office | 418 | 139 | $7.57 | $3,166 |
| 36415 Venipuncture Blood Collection | Office | 396 | 141 | $8.55 | $3,388 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 338 | 16 | $0.09 | $29.4 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 320 | 14 | $0.79 | $252 |
| 80053 Clinical Chemistry | Office | 289 | 114 | $10.28 | $2,970 |
| 99215 Office E&M - Established | Office | 284 | 150 | $129.15 | $37K |
| 99215 Office E&M - Established | Facility | 146 | 79 | $111.89 | $16K |
| 99214 Office E&M - Established | Office | 76 | 70 | $75.05 | $5,703 |
| 96413 Chemotherapy Administration | Office | 75 | 36 | $95.78 | $7,184 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 72 | 17 | $4.59 | $331 |
| 96372 Injection Administration | Office | 66 | 28 | $11.04 | $729 |
| 96367 Intravenous Infusion, Hydration | Office | 53 | 21 | $21.41 | $1,135 |
| 82784 Immunoassay | Office | 51 | 22 | $9.11 | $465 |
By year: 2022 $1.2M for 72,631 services; 2023 $1.9M for 92,724 services; 2024 $1.0M for 44,821 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 418 | 139 | $7.57 | $3,166 |
| 36415 Venipuncture Blood Collection | 396 | 141 | $8.55 | $3,388 |
| 80053 Clinical Chemistry | 289 | 114 | $10.28 | $2,970 |
| 82784 Immunoassay | 51 | 22 | $9.11 | $465 |
| 84153 Clinical Chemistry | 39 | 23 | $17.05 | $665 |
| 82728 Clinical Chemistry | 37 | 27 | $13.36 | $494 |
| 83540 Clinical Chemistry | 35 | 25 | $6.34 | $222 |
| 84466 Clinical Chemistry | 35 | 25 | $12.50 | $438 |
| 84443 Clinical Chemistry | 33 | 13 | $16.46 | $543 |
| 82378 Clinical Chemistry | 27 | 11 | $18.58 | $502 |
Medicare prescription drug claims, 2024
In 2024, the drug Yoshio Inoue prescribed most often to Medicare patients was Oxycodone Hcl, with 77 prescriptions and refills. In total Yoshio Inoue wrote 1,243 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 77 | 77 | 23 | $1,138 |
| Prochlorperazine Maleate Generic | 71 | 71 | 37 | $933 |
| Xtandi Enzalutamide | 64 | 64 | Under 11 | $963K |
| Prednisone Generic | 62 | 80 | 27 | $386 |
| Anastrozole Generic | 62 | 175 | 22 | $1,091 |
| Ondansetron Hcl Generic | 47 | 49 | 23 | $609 |
| Dexamethasone Generic | 38 | 43 | 18 | $524 |
| Acyclovir Generic | 31 | 55 | 11 | $707 |
| Lorazepam Generic | 27 | 27 | 15 | $91.86 |
| Tamoxifen Citrate Generic | 27 | 51 | Under 11 | $560 |
| Abiraterone Acetate Generic | 27 | 27 | Under 11 | $46K |
| Ondansetron Odt Ondansetron | 26 | 26 | 15 | $353 |
| Letrozole Generic | 24 | 71 | 11 | $759 |
| Ibrance Palbociclib | 23 | 23 | Under 11 | $344K |
| Hydroxyurea Generic | 23 | 49 | Under 11 | $610 |
Brand drugs: - claims; generic drugs: 911 claims; opioid claims: 144.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yoshio Inoue $22.8 ($22.8 in general payments such as food, travel and fees) from 1 company. The largest payer was Novartis Pharmaceuticals Corporation with $22.8.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 1 | $22.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.